{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:01:43Z","timestamp":1787068903170,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12883-014-0200-5","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T22:06:08Z","timestamp":1412719568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sj\u00f6gren\u2019s syndrome and Neuromyelitis Optica spectrum disorders (NMOSD) - a case report and review of literature"],"prefix":"10.1186","volume":"14","author":[{"given":"Apoorva","family":"Jayarangaiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"200_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/01.md.0000119465.24818.98","volume":"83","author":"M Ramos-Casala","year":"2004","unstructured":"Ramos-Casala M, Anaya JM, Garcia-Carrasco M, Rosas J, Bov\u00e9 A, Claver G, Diaz LA, Herrero C, Font J: Cutaneous vasculitis in primary Sjogren\u2019s syndrome: classification and clinical significance of 52 patients. Medicine. 2004, 83: 96-100. 10.1097\/01.md.0000119465.24818.98.","journal-title":"Medicine"},{"key":"200_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jnnp.2005.075861","volume":"84","author":"A Theodoridou","year":"2008","unstructured":"Theodoridou A, Settas L: Demyelination in rheumatic diseases. Postgrad Med J. 2008, 84: 127-132. 10.1136\/jnnp.2005.075861.","journal-title":"Postgrad Med J"},{"key":"200_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.autrev.2009.04.005","volume":"9","author":"MJ Sa","year":"2009","unstructured":"Sa MJ: Acute transverse myelitis: a practical reappraisal. Autoimmun Rev. 2009, 9: 128-131. 10.1016\/j.autrev.2009.04.005.","journal-title":"Autoimmun Rev"},{"key":"200_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for Neuromyelitis Optica. Neurology. 2006, 66: 1485-1489. 10.1212\/01.wnl.0000216139.44259.74.","journal-title":"Neurology"},{"key":"200_CR5","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","volume":"84","author":"J Jacob","year":"2013","unstructured":"Jacob J, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, de Seze J: Current concept of neuromyelitis optica and neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2013, 84: 922-930. 10.1136\/jnnp-2012-302310.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"200_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/BF00588375","volume":"35","author":"L Pierot","year":"1993","unstructured":"Pierot L, Sauve C, Leger JM, Martin N, Koeger AC, Wechsler B, Chiras J: Asymptomatic cerebral involvement in Sj\u00f6gren\u2019s syndrome: MRI findings of 15 cases. Neuroradiology. 1993, 35: 378-380. 10.1007\/BF00588375.","journal-title":"Neuroradiology"},{"key":"200_CR7","first-page":"295","volume":"49","author":"D Nitescu","year":"2011","unstructured":"Nitescu D, Nicolau A, Caraiola S, Predeteanu D, Ionescu R, Tanasescu C: Neuromyelitis optica- complication or comorbidity of primary Sj\u00f6gren\u2019s syndrome. Rom J Intern Med. 2011, 49: 295-300.","journal-title":"Rom J Intern Med"},{"key":"200_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/ard.2007.077883","volume":"67","author":"N Sofat","year":"2008","unstructured":"Sofat N, Venables PJ: Is Sjogren\u2019s myelopathy Devic Disease?. Ann Rheum Dis. 2008, 67: 730-731. 10.1136\/ard.2007.077883.","journal-title":"Ann Rheum Dis"},{"key":"200_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0002-9343(93)90255-N","volume":"95","author":"R Spezialetti","year":"1993","unstructured":"Spezialetti R, Bluestein HG, Peter JB, Alexander EL: Neuropsychiatric disease in Sjogren\u2019s syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med. 1993, 95: 153-160. 10.1016\/0002-9343(93)90255-N.","journal-title":"Am J Med"},{"key":"200_CR10","doi-asserted-by":"crossref","unstructured":"Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE: Primary Sjogren\u2019s syndrome with central nervous system disease mimicking multiple sclerosis.Ann Intern Med 1986, 104:323.,","DOI":"10.7326\/0003-4819-104-3-323"},{"key":"200_CR11","doi-asserted-by":"crossref","unstructured":"Olsen ML, O\u2019Connor S, Arnett FC, Rosenbaum D, Grotta JC, Warner NB: Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study.Am J Med 1991, 90:479.,","DOI":"10.1016\/0002-9343(91)90609-2"},{"key":"200_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA: Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006, 59: 566-569. 10.1002\/ana.20770.","journal-title":"Ann Neurol"},{"key":"200_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"S Nielsen","year":"1997","unstructured":"Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP: Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci. 1997, 17: 171-180.","journal-title":"J Neurosci"},{"key":"200_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2011.08.043","volume":"311","author":"J Kira","year":"2011","unstructured":"Kira J: Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci. 2011, 311: 69-77. 10.1016\/j.jns.2011.08.043.","journal-title":"J Neurol Sci"},{"key":"200_CR15","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/art.27337","volume":"62","author":"KP Wandinger","year":"2010","unstructured":"Wandinger KP, Stangel M, Witte T, Venables P, Charles P, Jarius S, Wildemann B, Probst C, Iking-Konert C, Schneider M: Autoantibodies against aquaporin-4 in patients with neuro-psychiatric systemic lupus erythematous and primary Sjogren\u2019s syndrome. Arthritis Rheum. 2010, 62: 1198-1200. 10.1002\/art.27337.","journal-title":"Arthritis Rheum"},{"key":"200_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/2006\/586306","volume":"22","author":"B Weinshenker","year":"2006","unstructured":"Weinshenker B, Wingerchuk D, Pittock S: NMO-IgG a specific biomarker for neuromyelitis optica. Dis Markers. 2006, 22: 197-206. 10.1155\/2006\/586306.","journal-title":"Dis Markers"},{"key":"200_CR17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol. 2008, 4: 202-214.","journal-title":"Nat Clin Pract Neurol"},{"key":"200_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archneurol.2011.148","volume":"68","author":"A Uzawa","year":"2011","unstructured":"Uzawa A, Mori M, Masuda S, Kuwabara S: Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica. Arch Neurol. 2011, 68: 913-917. 10.1001\/archneurol.2011.148.","journal-title":"Arch Neurol"},{"key":"200_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/WNR.0b013e32832776f4","volume":"20","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita M, Nakatsuji Y, Moriya M, Okuno T, Kumanogoh A, Nakano M, Takahashi T, Fujihara K, Tanaka K, Sakoda S: Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport. 2009, 20: 508-512. 10.1097\/WNR.0b013e32832776f4.","journal-title":"Neuroreport"},{"key":"200_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/00207450903428970","volume":"120","author":"S Icoz","year":"2010","unstructured":"Icoz S, Tuzun E, Kurtuncu M, Durmus H, Mutlu M, Eraksoy M, Akman-Demir G: Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int J Neurosci. 2010, 120: 71-75. 10.3109\/00207450903428970.","journal-title":"Int J Neurosci"},{"key":"200_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature. 2006, 441: 235-238. 10.1038\/nature04753.","journal-title":"Nature"},{"key":"200_CR22","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awq177","volume":"133","author":"R Marignier","year":"2010","unstructured":"Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P: Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain. 2010, 133: 2578-2591. 10.1093\/brain\/awq177.","journal-title":"Brain"},{"key":"200_CR23","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"F Luchinetti","year":"2002","unstructured":"Luchinetti F: A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain. 2002, 125: 1450-1461. 10.1093\/brain\/awf151.","journal-title":"Brain"},{"key":"200_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/S0004-282X2012000100012","volume":"70","author":"D Sato","year":"2012","unstructured":"Sato D, Callegaro D, Lana-Peixoto MA, Fujihara K: Brazilian Committee for treatment and research in multiple sclerosis. Treatment of neuromyelitis optica; evidence based review. Arq Neuropsiquiatr. 2012, 70: 59-66. 10.1590\/S0004-282X2012000100012.","journal-title":"Arq Neuropsiquiatr"},{"key":"200_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","volume":"34","author":"J Sellner","year":"2010","unstructured":"Sellner J, Hemmer B, M\u00fchlau M: The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun. 2010, 34: 371-379. 10.1016\/j.jaut.2009.09.013.","journal-title":"J Autoimmun"},{"key":"200_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jns.2008.08.015","volume":"276","author":"K Heerlein","year":"2009","unstructured":"Heerlein K, Jarius S, Jacobi C: Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J Neurol Sci. 2009, 276: 184-186. 10.1016\/j.jns.2008.08.015.","journal-title":"J Neurol Sci"},{"key":"200_CR27","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuck","year":"1999","unstructured":"Wingerchuck DM, Hogancamp WF, O\u2019Brien PC: The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology. 1999, 53: 1107-1114. 10.1212\/WNL.53.5.1107.","journal-title":"Neurology"},{"key":"200_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","volume":"66","author":"A Jacob","year":"2009","unstructured":"Jacob A, Matiello M, Weinshenker BG, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ: Treatment of neuromyelitis optica with Mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol. 2009, 66: 1128-1133. 10.1001\/archneurol.2009.175.","journal-title":"Arch Neurol"},{"key":"200_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/rheumatology\/kei263","volume":"45","author":"F Falcini","year":"2006","unstructured":"Falcini F, Trapani S, Ricci L, Resti M, Simonini G, de Martino M: Sustained improvement of a girl affected with Devic\u2019s disease over 2 years of Mycophenolate mofetil treatment. Rheumatology (Oxford). 2006, 45: 913-915. 10.1093\/rheumatology\/kei263.","journal-title":"Rheumatology (Oxford)"},{"key":"200_CR30","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","volume":"68","author":"SH Kim","year":"2011","unstructured":"Kim SH, Kim W, Li XF, Jung IJ, Kim HJ: Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years. Arch Neurol. 2011, 68: 1412-1420. 10.1001\/archneurol.2011.154.","journal-title":"Arch Neurol"},{"key":"200_CR31","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","volume":"65","author":"A Jacob","year":"2008","unstructured":"Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, DeAngelis T, Matiello M, Cree BA: Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol. 2008, 65: 1443-1448. 10.1001\/archneur.65.11.noc80069.","journal-title":"Arch Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-014-0200-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0200-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0200-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0200-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:10:07Z","timestamp":1630548607000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-014-0200-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["200"],"URL":"https:\/\/doi.org\/10.1186\/s12883-014-0200-5","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]},"assertion":[{"value":"15 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"200"}}